The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021
by from Morbidity and Mortality Weekly Report (MMWR) on (#5HTW6)
In May 2021, after a systematic review of all available data,the Advisory Committee on Immunization Practices made an interim recommendation for use of the Pfizer-BioNTechCOVID-19 vaccine in adolescents aged 12-15 years for the prevention of COVID-19.